Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 11Obesity 4Sarcopenia 3Polycystic Ovary Syndrome 3Neoplasms 3Melanoma 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Malnutrition 2Lymphoma, Follicular 2Colorectal Neoplasms 2Breast Carcinoma In Situ 2Wound Infection 1Weight Loss 1Urinary Bladder Neoplasms 1Surgical Wound Infection 1Stomach Neoplasms 1Smoldering Multiple Myeloma 1Skin Neoplasms 1Psoriasis 1Precancerous Conditions 1Postoperative Complications 1Polyps 1Phagocyte Bactericidal Dysfunction 1Pain 1Paget's Disease, Mammary 1Overweight 1Osteoarthritis 1Olfaction Disorders 1Non-alcoholic Fatty Liver Disease 1

Interventions

Tamoxifen 25Radiotherapy 15Chemotherapy, Adjuvant 11Anastrozole 11Specimen Handling 10Neoadjuvant Therapy 8Letrozole 8Biopsy 7Radiation 6Mastectomy, Segmental 6Magnetic Resonance Spectroscopy 6Immunohistochemistry 5Gene Expression Profiling 5exemestane 4Surgical Procedures, Operative 4Sentinel Lymph Node Biopsy 4Radiotherapy, Intensity-Modulated 4Radiotherapy, Conformal 4Psychiatric Rehabilitation 4Mass Spectrometry 4Early Intervention, Educational 4Counseling 4afimoxifene 3Trastuzumab 3Surveys and Questionnaires 3Reverse Transcriptase Polymerase Chain Reaction 3Radiation Dose Hypofractionation 3Methods 3Mastectomy 3High-Energy Shock Waves 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Intraductal, Noninfiltrating × Docosahexaenoic Acids × Clear all
NCT01849250 2021-12-28

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

National Cancer Institute (NCI)

Phase 2 Completed
65 enrolled 11 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡